Literature DB >> 10194105

Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient.

P Ribaud1, C Scieux, F Freymuth, F Morinet, E Gluckman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194105     DOI: 10.1086/517222

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

Review 1.  Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.

Authors:  Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

2.  Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy.

Authors:  Bianca Heemskerk; Louise A Veltrop-Duits; Tamara van Vreeswijk; Monique M ten Dam; Sebastiaan Heidt; Rene E M Toes; Maarten J D van Tol; Marco W Schilham
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 3.  Post-allogeneic hematopoietic stem cell transplantation viral reactivations and viremias: a focused review on human herpesvirus-6, BK virus and adenovirus.

Authors:  Xin Wang; Shyam A Patel; Michael Haddadin; Jan Cerny
Journal:  Ther Adv Infect Dis       Date:  2021-05-24

Review 4.  Respiratory viral infections in transplant and oncology patients.

Authors:  Deepali Kumar; Atul Humar
Journal:  Infect Dis Clin North Am       Date:  2010-06       Impact factor: 5.982

Review 5.  Severe adenovirus pneumonia in immunocompetent adults: a case report and review of the literature.

Authors:  F A Hakim; I M Tleyjeh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02       Impact factor: 3.267

Review 6.  Treatment of respiratory virus infections.

Authors:  Yacine Abed; Guy Boivin
Journal:  Antiviral Res       Date:  2006-02-14       Impact factor: 5.970

Review 7.  [Treatment for viral respiratory infections: Principles of action, strategies, and future prospects].

Authors:  G Rohde; G Schultze-Werninghaus; T T Bauer
Journal:  Internist (Berl)       Date:  2004-04       Impact factor: 0.743

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.